General Information of Drug (ID: DMAFEX8)

Drug Name
ISIS 347573 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMAFEX8

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ISIS-EIF4E DMRN543 Non-small-cell lung cancer 2C25.Y Phase 2 [2]
ISIS 232828 DMYEPV8 Discovery agent N.A. Investigative [1]
ISIS 347577 DM36SRT Discovery agent N.A. Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
eIF4E-BP2 messenger RNA (eIF4E-BP2 mRNA) TTNBTCW 4EBP2_HUMAN Not Available [1]

References

1 US patent application no. 7,468,431, Modulation of eIF4E-BP2 expression.
2 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).